UTMD reports Q4/FY2024 results; specific figures not available in filing excerpt

UTAH MEDICAL PRODUCTS INC

2024-FY EPS reported $3.96 revenue$40,903,000

Press release dated Jan 28, 2025 contains financial data for three and twelve months ended Dec 31, 2024.
Specific revenue, EPS, and other metrics not provided in the filing text or exhibit excerpt.
Forward-looking statements for 2024 and beyond are included in the press release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.